These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 2297753

  • 1. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ, Brubaker PG, Hanna DE, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A, Mulders P, Oosterwijk E, Buijs W, Corstens F, Boerman O, Oyen W.
    Cancer Biother Radiopharm; 2004 Aug 01; 19(4):466-77. PubMed ID: 15453961
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 7. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
    Buchsbaum DJ, ten Haken RK, Heidorn DB, Lawrence TS, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z, Lichter AS.
    Int J Radiat Oncol Biol Phys; 1990 May 01; 18(5):1033-41. PubMed ID: 2347713
    [Abstract] [Full Text] [Related]

  • 8. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P, Koprowski H.
    Proc Natl Acad Sci U S A; 1988 Jul 01; 85(13):4852-6. PubMed ID: 3387441
    [Abstract] [Full Text] [Related]

  • 9. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
    Ceriani RL, Blank EW.
    Cancer Res; 1988 Aug 15; 48(16):4664-72. PubMed ID: 3396015
    [Abstract] [Full Text] [Related]

  • 10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 11. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
    van Gog FB, Brakenhoff RH, Snow GB, van Dongen GA.
    Cancer Immunol Immunother; 1997 Apr 15; 44(2):103-11. PubMed ID: 9177472
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ, Lawrence TS, Roberson PL, Heidorn DB, Ten Haken RK, Steplewski Z.
    Int J Radiat Oncol Biol Phys; 1993 Mar 15; 25(4):629-38. PubMed ID: 8454481
    [Abstract] [Full Text] [Related]

  • 13. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
    Buchegger F, Pèlegrin A, Hardman N, Heusser C, Lukas J, Dolci W, Mach JP.
    Int J Cancer; 1992 Feb 01; 50(3):416-22. PubMed ID: 1735611
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W.
    Int J Cancer; 1998 May 29; 76(5):738-48. PubMed ID: 9610734
    [Abstract] [Full Text] [Related]

  • 15. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R, Blumenthal R, Sharkey RM, Goldenberg DM.
    Cancer; 1994 Feb 01; 73(3 Suppl):816-23. PubMed ID: 8306265
    [Abstract] [Full Text] [Related]

  • 16. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.
    Sharkey RM, Goldenberg DM, Vagg R, Pawlyk D, Wong GY, Siegel JA, Murthy S, Levine GM, Izon D, Gascon P.
    Cancer; 1994 Feb 01; 73(3 Suppl):864-77. PubMed ID: 8306272
    [Abstract] [Full Text] [Related]

  • 17. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
    Slavin-Chiorini DC, Kashmiri SV, Schlom J, Calvo B, Shu LM, Schott ME, Milenic DE, Snoy P, Carrasquillo J, Anderson K.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
    [Abstract] [Full Text] [Related]

  • 18. The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice.
    Fujii T, Yamana H, Toh Y, Toh U, Fujita H, Shirouzu K, Morimatsu M.
    Surg Today; 1997 Dec 01; 27(11):1026-34. PubMed ID: 9413055
    [Abstract] [Full Text] [Related]

  • 19. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
    Endo K, Kamma H, Ogata T.
    J Natl Cancer Inst; 1988 Aug 03; 80(11):835-42. PubMed ID: 3392743
    [Abstract] [Full Text] [Related]

  • 20. Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.
    Yu MH, Roffler SR, Hwang WS, Tung E, Chen WL, Yeh MY.
    Gynecol Oncol; 1992 Oct 03; 47(1):93-101. PubMed ID: 1427409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.